China's exports of rare earth magnets fell in September, reigniting fears that the world's top supplier could wield its ...
ESMO: AlphaMedixTM phase 2 data support first-in-class potential of new targeted alpha therapy in gastroenteropancreatic neuroendocrine tumors New AlphaMedix data showed sustained and clinically ...
Who’d a thought a power-conference school from the scrub brush of Texas’ South Plains would be a tortilla chip off the old Gaucho block? Texas Tech fans ...
Responses were rapid and durable, and tumour shrinkage was observed in 82 percent of patients1 New findings from this investigational study build on the strength of the data for amivantamab in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback